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In many rodent brain regions, alcohol increases vesicular release of GABA, resulting in an
increase in the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) and the
magnitude of tonic GABAA receptor (GABAAR) currents. A neglected issue in translating
the rodent literature to humans is the possibility that phylogenetic differences alter the
actions of alcohol. To address this issue we made voltage-clamp recordings from granule
cells (GCs) in cerebellar slices from the non-human primate (NHP),Macaca fascicularis. We
found that similar to Sprague Dawley rats (SDRs), NHP GCs exhibit a tonic conductance
generated by α6δ subunit containing GABAARs, as evidenced by its blockade by the broad
spectrum GABAAR antagonist, GABAzine (10μM), inhibition by α6 selective antagonist,
furosemide (100μM), and enhancement by THDOC (10–20 nM) and THIP (500 nM). In
contrast to SDR GCs, in most NHP GCs (∼60%), application of EtOH (25–105mM) did
not increase sIPSC frequency or the tonic GABAAR current. In a minority of cells (∼40%),
EtOH did increase sIPSC frequency and the tonic current. The relative lack of response to
EtOH was associated with reduced expression of neuronal nitric oxide synthase (nNOS),
which we recently reported mediates EtOH-induced enhancement of vesicular GABA
release in rats. The EtOH-induced increase in tonic GABAAR current was significantly
smaller in NHPs than in SDRs, presumably due to less GABA release, because there were
no obvious differences in the density of GABAARs or GABA transporters between SDR and
NHP GCs. Thus, EtOH does not directly modulate α6δ subunit GABAARs in NHPs. Instead,
EtOH enhanced GABAergic transmission is mediated by enhanced GABA release. Further,
SDR GC responses to alcohol are only representative of a subpopulation of NHP GCs. This
suggests that the impact of EtOH on NHP cerebellar physiology will be reduced compared
to SDRs, and will likely have different computational and behavioral consequences.
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INTRODUCTION
Alcohol abuse is a leading cause of preventable death and ill-
ness, and the economic cost of alcohol abuse, including treat-
ment and healthcare, lost productivity and various adverse social
impacts is estimated to be $185 billion annually in the USA
alone (Harwood, 2000). Accordingly, a great deal of research is
devoted to identifying neural targets of alcohol, and to deter-
mining how alcohol actions at those targets impact the brain
and contribute to the development of alcohol abuse and depen-
dence (Lovinger and Crabbe, 2005; Enoch, 2008). It has long
been thought that a main action of alcohol is to enhance
GABAergic transmission, but until recently the specific mecha-
nisms of the supposed enhancement have been elusive (Lovinger
and Crabbe, 2005; Enoch, 2008; Helms et al., 2012). Recent
studies with Sprague Dawley rat (SDR) brain slice preparations
have determined that a dominant mechanism by which alcohol
(EtOH) enhances GABAergic transmission is via enhanced vesic-
ular release of GABA, with a resultant increase in the frequency
of GABAA receptor (GABAAR)-mediated spontaneous inhibitory
postsynaptic currents (sIPSCs) (Roberto et al., 2003; Criswell
et al., 2008; Theile et al., 2008). The EtOH-induced vesicular
GABA release can also increase the magnitude of tonic GABAAR
currents in cell types that express the specialized class of extrasy-
naptic GABAARs that generate tonic GABAAR currents (Carta
et al., 2004; Hanchar et al., 2005). More controversially, it is
also being debated whether the EtOH-induced increase in tonic
GABAAR current is simply due to the increased vesicular release
of GABA and consequent increase in ambient concentrations, or
whether there is also a direct potentiation of the GABAAR sub-
units that mediate tonic currents (Hanchar et al., 2005; Borghese
et al., 2006; Borghese andHarris, 2007; Botta et al., 2007a,b; Korpi
et al., 2007; Santhakumar et al., 2007).
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The two forms of EtOH-induced enhancement of GABAAR
currents are exemplified by cerebellar granule cells (GCs)
which express α6δ subunit-containing, extrasynaptic GABAARs
that generate a powerful tonic GABAAR-mediated conductance
(Brickley et al., 2001; Hamann et al., 2002a; Stell et al., 2003).
In electrophysiological studies of SDR cerebellar brain slices,
acute application of EtOH increases the frequency of sponta-
neous GABAergic IPSCs, and increases the magnitude of the
tonic GABAA-mediated current (Carta et al., 2004; Hanchar et al.,
2005; Kaplan et al., 2013). Importantly, in contrast to many
brain regions (e.g., hippocampus, nucleus accumbens, thalamus,
ventral tegmental area, substantia nigra) (Peris et al., 1992; Nie
et al., 2000; Liang et al., 2006; Jia et al., 2008; Theile et al., 2008,
2009), where EtOH only affects GABAAR transmission at con-
centrations far above those typically achieved during voluntary
consumption by rodents or humans (≥50mM), enhancement of
GC GABAAR transmission occurs at low, readily achieved con-
centrations of alcohol (5–30mM). Furthermore, although the
changes in tonic GABAAR currents that are induced by such low
concentrations of EtOH are small (1–5 pA), because of their con-
stant nature, tonic GABAAR currents make up 75% of the total
inhibitory current in GCs (Rossi and Hamann, 1998; Hamann
et al., 2002a), which combined with the electrically compact
nature of GCs (Rossi and Slater, 1993), enables such small tonic
currents to profoundly influence transmission through the cere-
bellar cortex (Hamann et al., 2002a; Duguid et al., 2012). Thus,
to the extent that EtOH actions at GABAARs influence acute
EtOH sensitivity or voluntary consumption levels (Belelli and
Lambert, 2005; Criswell et al., 2008; Kumar et al., 2009), the dis-
tinctively high sensitivity of GC GABAAR transmission makes
it a primary candidate mechanism. Indeed, a growing body of
research indicates that genetic differences in cerebellar process-
ing and cerebellar responses to alcohol contribute to susceptibility
to alcohol use disorders (AUDs) (Schuckit et al., 1996, 2005; Hill
et al., 2007; Hill, 2010; Herting et al., 2011; Cservenka and Nagel,
2012), but the mechanisms by which the cerebellum influences
the development of AUDs are not known.
Insight into cerebellar contributions to AUD risk comes from
studies of the low level of response (LLR) to EtOH pheno-
type, which is defined as requiring a higher dose of EtOH to
achieve a given effect. EtOH-induced static ataxia (body sway),
a form of cerebellar-dependent motor impairment, consistently
shows LLR in individuals with a family history of AUDs com-
pared to individuals without a family history of AUDs (Schuckit
et al., 1996, 2005). Thus, low cerebellar sensitivity to EtOH may
be a risk factor for AUDs. In support of this contention, the
magnitude of EtOH-induced ataxia shows an inverse relation-
ship with EtOH consumption and preference in some inbred
strains of mice (Gallaher et al., 1996; Yoneyama et al., 2008)
as well as lines of rodents selected for differences in alcohol
consumption (Malila, 1978; Bell et al., 2001, 2006) or in EtOH-
induced motor impairment (McClearn et al., 1981; Sarviharju
and Korpi, 1993). Importantly, cerebellar specific injections
of various drugs can inhibit systemically administered EtOH
induced-ataxia (Dar, 1995, 2011; Al Rejaie and Dar, 2006), clearly
indicating the central role of the cerebellum in mediating EtOH-
induced ataxia. Prompted by this consistent genetic relationship
between cerebellar sensitivity to EtOH and AUDs in humans and
excessive EtOH consumption in rodents, we recently examined
GC tonic GABAAR current responses to EtOH in a range of
rodent genotypes with divergent EtOH related phenotypes, and
we found that the magnitude and polarity of the response varied,
in a graded fashion, from strong enhancement in high sensitivity,
low EtOH consuming rodents to suppression in low sensitivity,
high EtOH consuming rodents (Kaplan et al., 2013). Thus, the
consistent genetic relationship between EtOH consumption lev-
els and cerebellar-dependent behavioral sensitivity to EtOH is
reflected at a cellular level by genetic differences in GC tonic
GABAAR current responses to EtOH.
There are several important but neglected issues in translating
the abundant rodent literature to humans. First, it is possible that
phylogenetic differences fundamentally alter the sites of action
or impact of alcohol. For example, tonic GABAAR inhibition is
known to be strongly regulated by astrocytic GABA transporters
(Rossi et al., 2003), and the density of astrocytic processes relative
to neuronal processes increases with phylogenetic advancement
(Oberheim et al., 2006). In fact, it is not known if primate neu-
rons exhibit tonic GABAAR mediated inhibition, or if they do,
whether they are sensitive to EtOH. Indeed, we recently deter-
mined that systemic injections of EtOH (1–2mg/kg) significantly
increase serum levels of the GABAAR enhancing neurosteroids,
pregenenolone and THDOC, in SDRs but not in NHPs (Porcu
et al., 2010). Thus, much of what has been learned about cel-
lular actions of EtOH in rodents may not translate to primates.
Finally, in the context of genetic variation in cerebellar sensitivity
to EtOH as a contributing factor to AUDs, most cellular stud-
ies have been conducted on genetically homogenous SDRs, who
are very low EtOH consumers (i.e., under free access paradigms,
they typically only consume 1–2 g/kg/day) (Duncan and Deitrich,
1980). Accordingly, the well documented EtOH enhancement of
GC tonic GABAAR currents in SDR GCs may be the cellular
phenotype of low risk for excessive EtOH consumption. Indeed,
our recent findings that EtOH enhances GC tonic GABAAR cur-
rents in low EtOH consuming rodent genotypes but suppresses
GC tonic GABAAR currents in high EtOH consuming rodent
genotypes (Kaplan et al., 2013) raises the translationally impor-
tant question: what is the response in NHPs, which on average
show an intermediate EtOH consumption phenotype, and, being
a genetically heterogenous population, show a wide range of
consumption phenotypes across individual NHPs?
To address these issues, we conducted voltage-clamp record-
ings fromGCs in cerebellar slices obtained from the NHP,Macaca
fascicularis. We found that similar to SDRs, NHP GCs exhibit a
tonic conductance that is generated by α6δ subunit containing
GABAA receptors. However, in contrast to SDR GCs, in most cells
(60%), acute application of EtOH (25–105mM) did not increase
sIPSC frequency or the amplitude of the tonic GABAAR cur-
rent. In a minority of cells (40%), EtOH did cause an increase
in sIPSC frequency that was accompanied by a small increase
in the amplitude of the tonic GABAAR current. Importantly,
the proportion of cells that responded to EtOH varied consider-
ably across individual NHPs, as does EtOH consumption. Thus,
in contrast to genetically homogeneous, low EtOH consuming
SDRs, in genetically diverse NHPs, EtOH-induced enhancement
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of GABAAR tonic currents is neither widespread nor homoge-
nous across individuals, making it a potential contributing factor
to genetic variation in sensitivity to and consumption of EtOH.
RESULTS
NHP GCs EXHIBIT PHASIC AND TONIC GABAAR CURRENTS
INDISTINGUISHABLE FROM SDR GCs
To characterize GABAAR-mediated inhibition in NHP GCs, we
conducted voltage-clamp recordings from GCs in thin cerebel-
lar slices. In all recordings, GCs were clamped at −60mV, with
ECl- set to near 0mV, so all GABAAR-mediated currents are
inward (downward deflections of holding current traces), and
conversely, blockade of GABAAR currents will result in out-
ward currents (upward deflections). Similar to what we and
others have reported for SDR GCs (Brickley et al., 1996; Wall
and Usowicz, 1997; Hamann et al., 2002a), NHP GCs exhibited
tonic GABAAR currents with superimposed phasic GABAAR-
mediated sIPSCs, both of which were blocked by the broad
spectrum GABAAR antagonist, GABAzine (10μM; Figure 1A).
The magnitude of the tonic GABAAR current, and the fre-
quency and magnitude of sIPSCs were nearly identical in NHP
and SDR GCs (Figures 1B,C; P > 0.05 for all, n = 37 NHP
GCs from 10 animals and 16 SDR GCs from 7 animals). We
previously determined that in SDR GCs, the tonic current is
mediated by extrasynaptically located GABAARs containing α6
and δ subunits, which endow the receptor with properties opti-
mized for sensing low ambient concentrations of extracellular
GABA (Brickley et al., 2001; Hamann et al., 2002a; Stell et al.,
2003). Accordingly, we used immunocytochemistry and confo-
cal fluorescence microscopy to determine if NHP GCs expressed
α6 and δ subunits (Figures 1D,E). Similar to the SDR cerebellum,
both the α6 and δ subunit are densely and selectively expressed
in a confluent pattern across the GC layer, presumably, based
on their numerical dominance, on GCs (Figures 1D,E). Next, we
used subunit selective ligands to confirm that NHP GC tonic
GABAAR currents were indeed mediated by GABAARs contain-
ing α6 and δ subunits (Figures 1F,G). The tonic GABAAR current
was reduced by furosemide [100μM, at which concentration
it is specific for GABAARs containing the α6 subunit (Korpi
et al., 1995; Hamann et al., 2002a), Figure 1F], and was enhanced
by the GABAAR agonist THIP [500nM, which at concentra-
tions up to 1μM is specific for GABAARs containing δ subunits
(Meera et al., 2011), Figure 1G]. Finally, NHP GC tonic GABAAR
currents were also enhanced by low, physiologically relevant con-
centrations of the neurosteroid THDOC (Figure 1H). These data
confirm that, similar to previous reports in SDR GCs, NHP
FIGURE 1 | NHP and SDR GCs exhibit similar magnitude tonic
currents mediated by α6 and δ subunit containing GABAARs. (A)
Example trace showing block of tonic current and sIPSCs by GABAAR
antagonist GABAzine (10μM) in GCs from NHPs. Note, in this and all
other figures, the dashed arrows point to an expanded time scale of
recording from different time points of the main traces (coming from
the region of the main trace that the back of the arrow extrapolates
to), showing sIPSCs and block by GABAzine. (B) Plot summarizing
mean amplitude of tonic current blocked by GABAzine (10μM) in NHP
(black; n = 37 GCs from 10 animals) and SDR (gray; n = 16 GCs from 7
animals) GCs. (C) Plot of mean frequency (left) and amplitude of
sIPSCs (right) in NHP (black; n = 71 GCs from 12 animals) and SDR
(gray; n = 64 GCs from 26 animals) GCs (D,E). Confocally acquired
fluorescence images of cerebellar slices from an NHP showing α6 (blue
stain in D) and δ (green stain in E) subunits of the GABAAR expression
exclusively in the granule cell layer (beneath the Purkinje cell layer,
labeled red with antibody to Calbindin). (F) Example trace (left panel)
showing block of tonic current by GABAAR antagonist furosemide
(100μM, at which concentration it is specific for GABAARs containing
the α6 subunit) in a GC from an NHP. Plot in right panel summarizes
mean amplitude of tonic current blocked by furosemide in NHP (black;
n = 53 GCs from 11 animals) and SDR (gray; n = 23 GCs from eight
animals) GCs. (G) Example trace (left panel) showing enhancement of
tonic current by GABAAR agonist THIP (500 nM, at which concentration
it is specific for GABAARs containing the δ subunit) in a GC from an
NHP. Plot in right panel summarizes mean amplitude of tonic current
induced by THIP in NHP (black; n = 5GCs from two animals) and SDR
(gray; n = 31 GCs from six animals) GCs. (H) Example trace (top panel)
showing enhancement of tonic current by GABAAR modulator THDOC
(100 nM) in a GC from an NHP. Plot in bottom panel summarizes mean
amplitude of tonic current induced by 10, 20, and 100 nM THDOC in
NHP GCs (n = 4, 6, and 3, respectively from two animals).
Furosemide-, THIP-, GABAzine-, and THDOC-induced currents are all
significantly different from zero P < 0.05, and none are significantly
different between species P > 0.05 (excluding THDOC which was not
examined in SDRs).
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GCs exhibit tonic GABAAR currents mediated by extrasynap-
tic α6δ-containing receptors (Hamann et al., 2002a). There were
no detectable differences between NHP and SDR GC GABAAR
mediated sIPSCs or tonic current (Figures 1B,C,F,G).
NHP GCs EXHIBIT A SPILLOVER COMPONENT TO
ELECTRICALLY-EVOKED GABAAR IPSCs
In SDR GCs, one apparent role of high affinity α6 containing
GABAARs is to respond to spillover of GABA from neighboring
active synapses that do not form direct synapses with the recoded
GC (Rossi and Hamann, 1998). In SDRs, this spillover response
manifests as a prolonged tail component to GABAAR IPSCs that
are evoked by electrical stimulation, which by its nature tends to
activate both connected synapses and neighboring but uncon-
nected synaptic afferents simultaneously. Similar to SDR GCs,
electrical stimulation of NHP GC afferents evoked a GABAAR-
mediated, phasic IPSC that was abolished by the broad spectrum
GABAAR antagonist, GABAzine (10μM, Figure 2A, n = 7). As
for SDR GCs, the electrically evoked IPSC (eIPSC) in NHP GCs
was significantly larger, and decayed much more slowly than
sIPSCs (Figures 2B–D, n = 4, P < 0.05 for both amplitude and
decay time). Furthermore, the decay time, but not the ampli-
tude of the eIPSC was significantly (P < 0.05) reduced by the α6
subunit specific antagonist, furosemide (100μM; Figures 2E–G,
n = 4). Thus, similar to SDR GCs, NHPGCs respond to transient
elevations of extracellular GABA induced by activation of multi-
ple neighboring but not directly connected synapses.
EtOH DOES NOT AFFECT GABAAR CURRENTS IN THE MAJORITY OF
NHP GCs
In SDRs, the GC GABAAR system is a well-documented primary
target of physiologically relevant concentrations of EtOH (5–
30mM) (Carta et al., 2004; Botta et al., 2007b; Olsen et al., 2007),
with EtOH-induced enhancement of GC sIPSC frequency and
tonic GABAAR current magnitude likely mediating many aspects
of acute intoxication and impairment. Surprisingly, although a
similar enhancement by EtOH was observed in some NHP GCs
(∼40%: 3 of 12 at 26mM, 6 of 19 at 52mM, 4 of 10 at 79mM,
12 of 30 at 105mM), in the majority of NHP GCs (∼60%: 9 of
12 at 26mM, 13 of 19 at 52mM, 6 of 10 at 79mM, 18 of 30 at
105mM) EtOH did not affect sIPSC frequency or the magnitude
of tonic GABAAR currents (Figures 3A,B). Accordingly, the mean
percent increase in sIPSC frequency and tonic GABAAR current
magnitude, averaged across NHP GCs, was significantly smaller
than SDR GCs at all doses of EtOH examined (Figures 3C,D). If
we excluded NHP GCs that did not respond to EtOH, and plot-
ted the mean impact of EtOH on NHP GCs that did respond
to EtOH, the impact on sIPSCs was similar between NHP and
SDR GCs, but the impact on the tonic GABAAR current was still
significantly reduced in NHP GCs (Figures 3E,F). Interestingly,
FIGURE 2 | Electrically evoked IPSCs exhibit a prolonged tail component
mediated by GABAARs containing the α6 subunit. (A) Example trace
showing that an electrically-evoked synaptic current, that is abolished by the
GABAAR antagonist, GABAzine (10μM), confirming that it was a
GABAAR-mediated IPSC. (B,C) Representative traces showing the sIPSC
(black) and eIPSC (gray) from the same NHP GC, overlaid at actual size (B)
and scaled to peak (C) to illustrate prolonged decay time of eIPSC relative to
the sIPSC in the same cell. Inset in (B) shows the early phase of sIPSC and
eIPSC at an expanded time scale. (D) Plots showing mean amplitude (top)
and 10–90% decay time (bottom) for sIPSCs and eIPSCs in the same NHP
GCs, n = 6 GCs from two animals. (E) Representative trace showing that
furosemide reduces the decay time of the eIPSC without affecting the peak
amplitude. Inset shows the early phase of the eIPSC at an expanded time
scale. (F,G) Plots of the mean impact of furosemide (and recovery after wash)
on the peak amplitude (F) and 10–90% decay time (G) of eIPSCs in NHP
GCs, normalized to the control values, n = 4 GCs from two animals.
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FIGURE 3 | EtOH enhancement of GC sIPSC frequency and tonic
GABAAR current magnitude is restricted and variable in NHPs. (A)
Representative data showing that EtOH can either increase sIPSC frequency
(insets) and potentiate the tonic GABAAR current magnitude (main trace left
panel) or have no impact on tonic GABAAR currents (right panel) or sIPSC
frequency (not shown) in NHP GCs. (B) Plot of proportion of GCs showing
potentiation or no effect of EtOH on tonic GABAAR currents and sIPSC
frequency in SDR (right, gray) and NHP (left, black) GCs. (C,E) Plot of the
mean percent increase in sIPSC frequency induced by EtOH for all cells
tested (C) or EtOH responding cells only (E) from SDRs (gray) and NHPs
(black) [∗ indicates significantly different, P < 0.05, n = 21–35 GCs from 9–20
animals for each dose of EtOH, see panel (B) for details of proportion of
responders and non-responders]. (D,F) Plot of the mean magnitude of the GC
GABAAR tonic current induced by EtOH for all cells tested (D) or EtOH
responding cells only (F) from SDRs (gray) and NHPs (black) [∗ indicates
significantly different, P < 0.05, n = 21–35 GCs from 9–20 animals for each
dose of EtOH, see panel (B) for details of proportion of responders and
non-responders]. Note, in all responding cells examined, subsequent
application of GABAzine (10μM) abolished all EtOH-induced currents. (G,H)
Plot of the proportion of GCs from individual animals that responded to EtOH
at any dose of EtOH tested. The distribution for SDRs and NHPs are plotted
in (G) and (H) respectively.
the proportion of cells that responded to EtOH was quite vari-
able from animal to animal, ranging from 0 to 100% responders
(Figures 3G,H), as would be expected in a genetically heteroge-
neous population, if the cellular response phenotype contributes
to genetic differences in EtOH related behaviors. As a further test
of NHP GC GABAAR sensitivity to EtOH, we also determined
that high concentrations of EtOH (52mM) also did not affect the
amplitude of eIPSCs, or the decay rate of the spillover component
(Figure 4). We did not examine EtOH actions on SDR evoked
IPSCs, since there were so few non-responders to examine.
LACK OF RESPONSE TO EtOH IS NOT DUE TO LACK OF FUNCTIONAL
AFFERENTS, OR DIFFERENCES IN GABAAR RECEPTOR OR GABA
TRANSPORTER DENSITY
Since in SDRs, themajority (Hanchar et al., 2005), if not all (Botta
et al., 2007a,b), of EtOH-induced increases in tonic GABAAR
currents is a consequence of increased extracellular GABA, via
increased vesicular release, we considered that the lack of effect
of EtOH in NHP GCs might result from a loss of the GC GABA
afferent Golgi cells due to damage during slicing. However, in
4 NHP GCs that did not respond to EtOH (105mM), subse-
quent application of the sodium channel blocker, TTX (500 nM),
strongly suppressed the frequency of sIPSCs (not shown; sIPSC
frequency= 0.66± 0.34 and 0.04± 0.02Hz before and after TTX,
respectively; P < 0.02) and the magnitude of the tonic GABAAR
current (Figures 5A,B). Indeed, the TTX-induced suppression of
tonic GABAAR currents in non-responding NHP GCs was signif-
icantly greater than TTX-induced suppression of tonic GABAAR
currents in SDRGCs (TTX-induced current was 12.05± 1.27 and
FIGURE 4 | Electrically evoked IPSCs are not affected by EtOH. (A)
Example trace showing that an eIPSC in an NHP GC is not affected by
EtOH (52mM). (B) Plot of the mean percent change, induced by EtOH
(52mM), of the peak amplitude (left bar) and 10–90% decay time (right bar)
of eIPSCs in NHP GCs, normalized to the control values (before and after
EtOH), n = 4 GCs from two animals.
4.35 ± 0.60 pA in non-responding NHP and SDR GCs respec-
tively, which corresponded to 38.45 ± 4.05 and 16.18 ± 2.96%,
respectively, of the GABAzine-induced current in the same cell;
P < 0.001 for both measures), suggesting that vesicular release of
GABA from healthy Golgi cells plays a more prominent role in
regulating GABAAR currents in NHP GCs (even non-responding
NHP GCs) than in SDR GCs. Thus, the lack of enhancement by
EtOH is not due to lack of action potential competent Golgi cells,
able tomodulate the extracellular GABA around the recorded GC.
We next considered that if NHP GCs had a lower density
of GABAARs, then EtOH-induced GABA release at neighboring
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FIGURE 5 | Lack of response to EtOH is not due to damaged Golgi cells
or differences in GABAAR or GABA transporter density. (A)
Representative trace showing that in an NHP GC that did not respond to
EtOH (105mM), subsequent application of TTX (500 nM) significantly
reduced the magnitude of the tonic GABAAR current. Dashed doublet of gray
diagonal lines indicates a gap in the current shown to conserve figure space.
(B) Plot of mean percent block by TTX (500 nM) of tonic GABAAR current,
expressed as the percent of the tonic GABAAR current blocked by the broad
spectrum GABAAR antagonist, GABAzine (10μM, left bar) or the α6 specific
antagonist, furosemide (100μM, right bar), n = 7 and 6 GCs respectively
from two animals. (C–E) Plots of mean current induced by THIP (10μM, C),
GABA (5μM, D), and the ratio of the amplitudes of those responses in
individual GCs (E). For each plot, data from NHPs and SDRs are plotted in
black and gray respectively (n = 4–10 GCs each from 2 to 3 animals).
synapses may not generate large enough currents to be detected
in NHP GCs. However, bath application of a concentration of
THIP (10μM) or GABA (5μM) that should activate all subtypes
of GABAARs produced similar magnitude currents in NHP and
SDR GCs (Figure 5C), suggesting similar densities of all subtypes
of GABAARs, similar to what we observed for the subtypes that
mediate tonic GABAAR currents under control conditions, which
are also of similar density (Figures 1F,G). Another possibility we
considered was that higher densities of GABA transporters in
NHPs might reduce EtOH-induced GABA spillover and/or accu-
mulation in the extracellular space, thereby preventing enhance-
ment of tonic GABAAR currents. To assess GABA transporter
functional density, we used a technique that we have used previ-
ously to assess both glutamate (Hamann et al., 2002b, 2005) and
GABA (Rossi et al., 2003; Allen et al., 2004) transporter densities,
whereby we do cell by cell comparisons of the ratio of response to
GABA, which is taken up by GABA transporters, and THIP which
is not taken up by GABA transporters. Since the density of GABA
transporters will only influence the concentration of GABA in the
extracellular space, and will not affect the concentration of THIP,
then differences in GABA transporter densities will change the
ratio of response to the two GABAAR agonists. However, there
was no significant difference in the ratio of responses to THIP and
GABA between NHP and SDR GCs (Figure 5E), suggesting simi-
lar functional densities of GABA transporters. Taken together, our
data indicate that GABAAR pharmacology and physiology, GABA
transporter functional density, and Golgi cell viability are similar
between NHPs and SDRs, and thus the lack of impact of EtOH on
sIPSC frequency and tonic GABAAR current in NHP GCs is due
to a lack of impact on Golgi cell firing.
In addition to comparing NHP GCs to SDR GCs, we consid-
ered whether there were any obvious differences between EtOH-
responding and non-responding NHPs. Although the magnitude
of the tonic GABAAR current was similar in responding and non-
responding NHP GCs (Furosemide-induced current = 15.8 ±
2.19 and 21.39 ± 3.05 pA in responding and non-responding
NHP GCs, respectively; GABAzine-induced current = 23.65 ±
5.78 and 27.13 ± 6.73 pA in responding and non-responding
NHP GCs respectively; P > 0.05 for both), the baseline fre-
quency of sIPSCs was significantly lower in non-responding NHP
GCs (0.61 ± 0.16 and 0.29 ± 0.11Hz in responding and non-
responding NHP GCs respectively; P < 0.05). These data suggest
that Golgi cells that form direct synaptic contacts with non-
responding NHP GCs are either fewer in number or fire action
potentials less frequently, but that the ambient concentration of
GABA surrounding EtOH non-responding NHP GCs is similar
to that around responding NHP GCs.
REDUCED AND VARIABLE RESPONSE TO EtOH IS MIRRORED BY
REDUCED AND VARIABLE EXPRESSION OF nNOS
We recently determined that in SDRs, EtOH-induced enhance-
ment of GC tonic GABAAR currents is triggered by EtOH sup-
pression of neuronal nitric oxide synthase (nNOS), which in turn
drives increased Golgi cell action potential firing and consequent
increased vesicular release of GABA (Kaplan et al., 2013). We
also found that prototypically high EtOH consuming C57BL/6J
(B6) mice had significantly lower levels of expression of nNOS
in the GC layer, and accordingly that EtOH enhancement of GC
GABAAR current only occurred in 15% of B6 GCs (Kaplan et al.,
2013). We therefore reasoned that the relative lack of response of
NHP GC tonic GABAAR currents was due to a similarly reduced
expression of nNOS. To test this hypothesis, we used immunocy-
tochemistry and confocal microscopy to examine nNOS expres-
sion in the GC layer of the NHP cerebellum (Figure 6). Although
we did detect nNOS expression in the NHP cerebellum, and the
subcellular localization pattern was qualitatively similar to what
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FIGURE 6 | Differential expression of nNOS mirrors differences in
EtOH-induced potentiation of GC GABAAR transmission. (A) Confocally
acquired images of immunocytochemistry for nNOS (red) and nuclear stain
Hoechst (blue) in the granule cell layer of NHP cerebellum. Arrows point to
examples of GC somas completely surrounded by nNOS signal, and
∗ indicate examples of GC somas completely devoid of nNOS encirclement.
(B) Plot of mean percent encirclement of GC soma/nuclei (determined as
described in Kaplan et al. (2013); n = 2,569 GCs from six animals).
we reported for SDRs (i.e., it was frequently concentrated in a halo
surrounding GC nuclei; Figure 6A), in support of our hypothe-
sis, the presence of nNOS expression around GC nuclei was more
variable, and generally less prevalent than what we reported for
SDRs (Figures 6A,B) (Kaplan et al., 2013). In particular, while
someNHPGCs were entirely surrounded by nNOS [similar to the
majority of SDR GCs (Kaplan et al., 2013)], the majority of NHP
GCs were not fully surrounded by nNOS, and many NHP GCs
were entirely devoid of nNOS. These data, combined with our
recent studies in several rodent genotypes with divergent EtOH
related phenotypes, suggest that the relatively reduced and more
varied response of NHP GCs to EtOH stems from reduced and
more varied expression of nNOS.
DISCUSSION
Using voltage-clamp recording from GCs in acutely prepared
slices of NHP cerebellum, we have determined that GABAAR-
mediated transmission onto NHP GCs is physiologically and
pharmacologically indistinguishable from SDRGCs (Figures 1, 2,
5). In particular, the frequency and amplitude of sIPSCs and the
magnitude of tonic GABAAR currents are similar, the response
of the tonic GABAAR current to various subunit specific ligands
is similar, and the density of GABAAR receptors and subunits,
and the density of GABA transporters are similar. Thus, despite
potential differences in the ratio of astrocytes and neurons across
phylogenetic advancement (Oberheim et al., 2006), the NHP GC
synapse functions similarly to SDR GCs, in that they both exhibit
traditional phasic synaptic IPSCs and sense spillover of GABA
from neighboring unconnected synapses as well as the ambient
concentration of GABA in the extracellular space. Despite nearly
identical baseline properties, in striking contrast to SDR GCs
(Carta et al., 2004; Hanchar et al., 2005), in the majority of NHP
GCs, EtOH does not affect GABAARmediated transmission, even
at extremely high, non-physiological concentrations (Figure 3).
MECHANISMS ENABLING GC RESPONSES TO AMBIENT AND
SPILLOVER GABA
In SDRs, the ability of GCs to sense spillover and ambient GABA
is thought to be achieved through a combination of receptor phar-
macology and subcellular morphological interactions (Rossi and
Hamann, 1998; Brickley et al., 2001; Hamann et al., 2002a; Stell
et al., 2003). In particular, inclusion of the α6 and δ subunits into
functional GABAARs endow the receptor with an order of mag-
nitude higher affinity for GABA than other GABAARs (Saxena
andMacdonald, 1996), enabling them to sense the low concentra-
tions of ambient GABA that occur in the extracellular space and
during spillover from neighboring synapses (Rossi and Hamann,
1998; Hamann et al., 2002a). Further facilitation is achieved by
the glomerular structure in which Golgi cell to GC synapses
occur (Rossi and Hamann, 1998). The glomerulus is comprised
of approximately 50 neighboring GC synapses in close proximity,
and rather than being separated by astrocytic processes as occurs
in the forebrain, they are collectively encased by an astrocytic
sheath (Jakab and Hamori, 1988), thereby facilitating transmit-
ter cross talk among intraglomerular synapses, and retention of
ambient transmitter in the local extracellular space (Rossi and
Hamann, 1998).
Using immunohistochemistry, we determined that similar to
SDRs, both the α6 and δ subunit of the GABAAR are densely and
selectively expressed by NHP GCs (Figures 1D,E). Furthermore,
using α6 and δ subunit selective ligands, we confirmed that the
tonic GABAAR is mediated by GABAARs containing both of these
subunits, and that the spillover component of the eIPSC is medi-
ated by GABAARs containing at least the α6 subunit (Figure 2).
Because we primarily test for the presence of the δ subunit with
the selective agonist, THIP, and interpreting actions of agonists
on synaptic decay rates is complicated, we were unable to test for
the contribution of δ subunits to the spillover component. Taken
together our immunohistochemical and pharmacological stud-
ies suggest that similar to SDRs, NHP GCs express both the α6
and δ subunits of the GABAAR, and that their presence in func-
tional GABAARs enables NHPGCs to sense ambient and spillover
GABA.
To our knowledge a detailed 3-dimensional reconstruction of
electron micrographs of the GC layer has only been done in the
rat (Jakab and Hamori, 1988). However, an earlier study using
light microscopic examination of Golgi preparations combined
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with single plane electron microscopy suggest that the primary
features of the glomerulus in the NHP is similar to that in SDRs,
including an astrocytic sheath aroundmultiple GC dendrites (Fox
et al., 1967). Thus, the molecular, pharmacological, and anatom-
ical characteristics of the Golgi cell to GC synapse appear to be
relatively conserved across species, resulting in remarkably similar
physiological characteristics (Figures 1, 2).
EtOH DOES NOT AFFECT GABAAR CURRENTS IN THE MAJORITY OF
NHP GCs
It is well established that the SDR GC GABAAR system is highly
sensitive to EtOH, with concentrations as low as 10mM (i.e., the
equivalent of those achieved by an adult human consuming ∼2
units of alcohol) substantially increasing sIPSC frequency and
tonic GABAAR current magnitude (Carta et al., 2004; Hanchar
et al., 2005). Furthermore, because of the electrically compact
nature of GCs, their central role in signal propagation through
the cerebellar cortex, and the dominant role of tonic GABAAR
currents in mediating GC GABAAR inhibition, even small alter-
ations of the tonic GABAAR current powerfully influence signal
propagation through the cerebellar cortex (Hamann et al., 2002a;
Duguid et al., 2012). Thus, even low concentrations of EtOH
significantly disrupt SDR cerebellar processing (Hanchar et al.,
2005). In contrast, other than the central nucleus of the amyg-
dala (Roberto et al., 2003), the GABAAR system in most other
brain nuclei (e.g., hippocampus, nucleus accumbens, thalamus,
ventral tegmental area, and substantia nigra; Peris et al., 1992;
Nie et al., 2000; Liang et al., 2006; Jia et al., 2008; Theile et al.,
2008, 2009), is not affected by concentrations of EtOH below
∼50mM EtOH. Given that even the most avid rodent con-
sumers of EtOH (e.g., high drinking in the dark selected mice,
C57BL/6 mice and alcohol preferring rats) only voluntarily con-
sume enough EtOH to reach BECs of ∼20–25mM, it is likely
that in rodents, the GC GABAAR system is a primary mediator
of symptoms of acute intoxication. However, we found that in the
majority (∼60%) of NHP GCs, even extremely high concentra-
tions of EtOH (105mM) do not affect any aspect of GABAAR
transmission (Figure 3). The lack of response to EtOH was not
due to a lack of functional Golgi cell afferents, because blocking
action potentials with TTX substantially reduced the frequency
of sIPSCs and the magnitude of the tonic GABAAR current
(Figures 5A,B), clearly indicating that functional Golgi cells were
present, connected, and able to influence GC GABAAR currents.
The lack of response to EtOH also did not reflect differences in the
density of GABAARs or GABA transporters, as pharmacological
assessment of these parameters found no significant differences
from SDRs (Figures 5C–E). Thus, the most parsimonious expla-
nation for the lack of response to EtOH is that in contrast to SDRs,
the majority of NHP Golgi cells do not respond to EtOH with an
increase in action potential firing, and thus there is no increase in
vesicular GABA release, which normally mediates EtOH-induced
increases in both sIPSC frequency and the tonic GABAAR current
magnitude (Carta et al., 2004; Botta et al., 2007a,b, 2010, 2012).
Indeed, the relative lack of, and highly variable response of NHP
GCs to EtOH is mirrored by reduced and highly variable cere-
bellar expression of nNOS (Figure 6), the suppression of which
mediates EtOH-induced excitation of Golgi cells and consequent
enhancement of GC GABAAR currents in SDRs (Kaplan et al.,
2013).
Although we did not systematically examine whether direct
interactions of EtOH with GABAARs contribute to the EtOH-
induced enhancement of tonic GABAAR currents, the fact that
EtOH did not affect the tonic current at all in ∼60% of cells
(Figure 3B), and did not affect the peak or spillover component
of eIPSCs (Figure 4), suggests that even high concentrations of
EtOH do not directly affect NHP GC GABAAR sensitivity to
GABA (Borghese et al., 2006; Botta et al., 2007a,b; Korpi et al.,
2007; Olsen et al., 2007). Instead, when EtOHdoes affect NHPGC
GABAAR transmission it is via excitation of Golgi cells and con-
sequent increased vesicular release of GABA, similar to what has
been reported for SDRs (Carta et al., 2004; Botta et al., 2007a,b,
2010, 2012).
In NHP GCs that did respond to EtOH, similar to SDR GCs,
the response consisted of an increase in sIPSC frequency and an
associated increase in the magnitude of the tonic GABAAR cur-
rent (Figures 3A–D). However, although the increase in sIPSCs
was similar to SDR increases, themagnitude of the EtOH-induced
increase in the tonic GABAAR current was still significantly less
than what occurred in SDR GCs (Figures 3E,F). This suggests
that despite being connected to an EtOH-responding Golgi cell,
neighboring, not directly connected Golgi cells did not respond
to EtOH, resulting in less spillover and accumulation of GABA in
the extracellular space, compared to SDRs, in which all Golgi cells
respond to EtOH.
Responding NHP GCs responded to concentrations of EtOH
as low as 25mM, but because the currents are small and uncom-
mon, combined with restricted access to NHP tissue, we did not
test lower concentrations. Taken together, our data suggest that
the impact of EtOH on cerebellar processing in NHPs is likely to
be less substantial and less widespread than in SDRs.
POTENTIAL RELEVANCE TO EtOH RELATED BEHAVIORAL PHENOTYPES
In SDRs, EtOH-induced enhancement of GABAAR currents
occurs in ∼95% of GCs (Figure 3B). Accordingly, EtOH will
essentially dampen signal transmission through GCs confluently
across the SDR cerebellum. The impact of such widespread
dampening on cerebellar output is not entirely certain, because
although GCs provide glutamatergic excitation to Purkinje cells
(the sole output of the cerebellar cortex), they also provide such
excitation to molecular layer interneurons, which, in turn, inhibit
Purkinje cells (Duguid et al., 2012; Cesana et al., 2013). Our pre-
vious slice studies determined that widespread suppression of GC
GABAAR inhibition increased the input to output relationship
of transmission through the cerebellar cortex (Hamann et al.,
2002a), but slice studies inevitably alter the full spatiotemporal
relationship of inhibitory and excitatory neurons that exist in the
intact cerebellum. In any event, our finding that EtOH enhances
GABAAR transmission in only ∼40% of NHP GCs (Figure 3B)
suggests that the impact of EtOH on signal transmission through
the cerebellar cortex of NHPs will be reduced relative to SDRs.
Furthermore, depending on the spatial distribution of cells that
respond to EtOH, downstream interactions with molecular layer
interneurons and Purkinje cells (Duguid et al., 2012; Cesana et al.,
2013; Cramer et al., 2013) could result in EtOH having opposite,
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or at least varying impact on cerebellar output in different cere-
bellar sub regions. It is also worth noting that although NHP GC
tonic GABAAR currents are highly sensitive to enhancement by
the neuroactive steroid, THDOC (Figure 1H), our recent stud-
ies determined that in contrast to SDRs, systemic EtOH does not
increase serum levels of GABAAR-active neurosteroids in NHPs
(Porcu et al., 2010). This lack of increase in GABAAR-active
steroidsmay further reduce cerebellar responses to systemic EtOH
in NHPs relative to SDRs. In addition to acute actions of EtOH,
the relative lack of response of NHP GC GABAAR currents to
EtOH could underlie reported species differences in molecular
adaptation during chronic EtOH consumption. In particular, in
a variety of models of chronic EtOH exposure, rodent cerebellum
exhibits changes in GABAAR subunit expression, including the α6
and δ subunits (up and down regulated, respectively) that medi-
ate tonic GABAAR currents (Marutha Ravindran et al., 2007a,b).
In contrast, we reported previously that the expression of the α6
subunit in the NHP cerebellum is not altered by chronic vol-
untary EtOH consumption (Sullivan et al., 2005). While such
differences may simply reflect the higher levels of EtOH used in
rodent chronic exposure models, it could also stem from the lack
of acute response that we report here (i.e., if GABAAR adaptations
are homeostatic, then the lack of acute response to EtOH in NHP
GCs may preclude adaptation during chronic EtOH exposure).
Beyond differences between NHPs and SDRs, we discovered
that the proportion of NHP GCs that responds to EtOH varies
widely (from 0 to 100%) across individual NHPs (Figure 3H).
This wide individual variation in sensitivity is intriguing because
in the human literature, variations in sensitivity to EtOH-induced
body sway (a presumed cerebellar dependent behavioral impact
of EtOH) correlates with genetic risk for developing an AUD. In
particular, a LLR to EtOH-induced body sway is significantly cor-
related with a family history of alcoholism and, in longitudinal
studies, with the development of alcoholism (Schuckit et al., 1996,
2005). Variation in behavioral sensitivity must be driven by vari-
ation in sensitivity at a cellular/molecular level, but prior to our
study of genetically heterogeneous NHPs, no such individual vari-
ation at a cellular level had been reported, presumably because
most rodent models, whether high or low EtOH consumers, are
genetically homogeneous. Thus, variation in the proportion of
GCs that respond to EtOH could be a cellular substrate of the
LLR to EtOH-induced body sway, and thus a potential cellu-
lar/molecular risk factor for AUDs. It would therefore be useful to
identify the molecular determinants of EtOH-induced enhance-
ment of GC GABAAR currents (Hanchar et al., 2005; Botta et al.,
2007b, 2010, 2012; Diaz et al., 2011; Kaplan et al., 2013), and to
determine whether manipulating GC GABAAR current responses
to EtOH can influence EtOH consumption in rodent and NHP
models.
LIMITATIONS OF THIS STUDY
Access to NHP tissue is rare but valuable. Thus, while such access
has the potential to provide translationally important insights
not possible to glean from rodent studies, it does bring with it
a variety of experimental limitations. In particular, we rely on
control NHPs destined for euthanasia as part of other larger
behavioral studies, which typically only provide about 4–8 use-
able subjects per year. Thus, while our study is not as thorough
as would be possible with easily accessible rodents, the individ-
ual experiments are sound, and our findings should prompt an
important reconsideration of the actions of alcohol in the clinical
context, and should serve as an important stimulus and start-
ing point for further future studies. Nonetheless, some potential
limitations merit consideration. First, we conducted all experi-
ments at room temperature (22–24◦C), which could in principle
affect responses to EtOH.We opted for room temperature record-
ing because in our experience recordings tend to be more stable
(which is particularly crucial when recording small modifications
of small currents), and because heating solutions in a room tem-
perature room increases degassing of the solution, which creates
bubbles, which can lodge in tubing and/or dislodge, either of
which can disrupt a recording. Furthermore, over the years, we
have varied temperature to determine if doing so affects various
outcomes, and although most responses are faster at higher tem-
peratures, few if any observations are fundamentally altered by
changes in temperature (e.g., Rossi and Hamann, 1998; Hamann
et al., 2005). For these reasons, to optimize our success rate with
very limited access to NHP tissue, we chose to record at room
temperature. Nonetheless, it is conceivable that lowered temper-
ature has a differential impact on responses in rodents compared
to NHPs, and such a differential response could explain the dif-
ferences between rat and NHP responses to EtOH that we report.
However, our finding that nNOS expression in NHPs is reduced
and more variable, relative to SDRs (Figure 6), combined with
our recent finding that EtOH-induced enhancement of GABAAR
sIPSCs and tonic GABAAR currents in SDRs and other rodent
genotypes is mediated by EtOH inhibition of nNOS (Kaplan et al.,
2013) provides a plausible alternative mechanism, i.e., the rela-
tive lack of response of NHP GCs to EtOH is likely due to the
lack of nNOS expression. In this regard, another limitation of
this study is that because of the aforementioned limited access
to NHP tissue, we have not yet confirmed that similar to our
findings in rodents (Kaplan et al., 2013), EtOH inhibits nNOS
in primates, with a resultant excitation of Golgi cells and conse-
quent increased vesicular release of GABA. Such an undertaking
should be a priority in future studies of NHP GC responses to
EtOH.
Although previous studies have established that there is a con-
sistent genetic relationship between cerebellar-dependent behav-
ioral sensitivity to EtOH and predilection to AUDs in humans and
excessive EtOH consumption in rodents (Malila, 1978; McClearn
et al., 1981; Gallaher et al., 1996; Schuckit et al., 1996, 2005;
Bell et al., 2001, 2006; Sarviharju et al., 2006; Yoneyama et al.,
2008), to our knowledge no such relationship between NHPs and
rodents or between individual NHPs has been established, and
it was beyond the scope of this study to establish such a rela-
tionship. However, our finding that NHP GC GABAAR current
responses to EtOH are reduced and more varied compared to low
EtOH consuming and genetically homogeneous SDRs (Figure 3),
combined with our findings that EtOH response magnitude and
polarity correlates with sensitivity to and consumption of EtOH
in rodent models (Kaplan et al., 2013) highlights the GCGABAAR
system as a target to manipulate, to test whether the sensitivity
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to or consumption of EtOH are influenced by GC responses to
EtOH.
Finally, because of complications associated with repeated
applications of EtOH and incomplete washout of various
GABAAR ligands, we did not examine responses to EtOH in mul-
tiple cells within a slice, and thus did not determine the overall
3-dimensional spatial distribution of NHP GCs that responded
to EtOH and those that did not respond to EtOH. Such infor-
mation will be important for considering what the net impact of
EtOH will be on signal transmission through the NHP cerebel-
lar cortex. Does EtOH dampen signal transmission or signal to
noise ratios (Duguid et al., 2012) in some regions but enhance it
or not affect it in other regions? Does it enhance signaling contrast
between individual cells or cerebellar subregions? Future map-
ping of EtOH response phenotype across cerebellar subregions,
and perhaps detailed mapping of nNOS distribution would help
answer such computational questions.
SUMMARY AND CONCLUSION
The basic physiological and pharmacological properties of
GABAAR transmission onto NHP GCs are virtually identical to
those in SDR GCs. In contrast, while EtOH enhances both sIPSC
frequency and tonic GABAAR currents in nearly all SDR GCs,
such enhancement is far less prevalent in NHP GCs, and the
prevalence varies considerably across individual NHPs, possibly
providing a cellular substrate of variation in behavioral sensitivity
to acute EtOH intoxication. Given that low sensitivity to EtOH-
induced disruption of cerebellar processing is a risk factor for
alcoholism in humans, our results further highlight variation in
GC GABAAR sensitivity to EtOH as a potential cellular contri-
bution to such risk (Kaplan et al., 2013). Future studies should
examine howmodulating GC GABAAR sensitivity to EtOH influ-
ences EtOH intoxication and consumption in both rodent and
NHP animal models.
METHODS
Non-human primate (NHP) care and all NHP procedures were
approved by the Oregon National Primate Research Center
Animal Care and Use Committee at Oregon Health Science
University and carried out according to the NIH Guidelines
for the Care and Use of Mammals in Neuroscience and
Behavioral Research. Euthanasia was carried out according to the
American Veterinary Medical Association (AVMA) Guidelines on
Euthanasia as detailed in (Daunais et al., 2010) (and below in
supporting information). All primates used were euthanized as
control subjects in various ongoing studies unrelated to the cur-
rent study, and no additional primates were euthanized for the
purposes of this study.
CEREBELLAR SLICE PREPARATION
For NHPs (6–18 year old males and females), after ketamine seda-
tion, animals were intubated and maintained on a mixture of 1 L
O2 and room air in order to ensure O2 saturation. Sodium pen-
tobarbital was given to establish deep anesthesia during which
the calvaria was removed and the brain with dura intact was
exposed as previously described (Davenport et al., 2013). The
monkeys were then perfused through the heart with cold, oxy-
genated artificial cerebrospinal fluid and the brain was removed
within 5min after death and prepared for electrophysiology.
Supporting Information contains the full details of this proce-
dure. Upon removal of the brain, the cerebellum was rapidly
isolated and immersed in ice cold (0–2◦C), low-sodium, ACSF
composed of sucrose 220, KCl 2, NaH2PO4 1.5, MgSO4 1.2,
d-glucose 10, NaHCO3 26, and CaCl2 0.2 and transported to
the electrophysiology laboratory. The cerebellum was cut into
quarter segments, two of which were mounted, parallel to the
sagittal plane, in a slicing chamber filled with ice cold (0–2◦C),
low sodium ACSF. In initial experiments with SDRs (20–60 day
old males and females), the methods and solutions for tissue iso-
lation and slicing were exactly as described previously (Rossi and
Hamann, 1998; Hamann et al., 2002a; Rossi et al., 2003; Kaplan
et al., 2013). However, upon discovering the lack of response to
EtOH in NHP GCs, we considered that such differences could
result from differences in how we harvested NHP and SDR tis-
sue. Accordingly, we conducted additional experiments in which
fully adult SDRs were used (4–6 months old), and animal treat-
ment and tissue harvest were conducted as similarly as possible
to NHP tissue harvest. Animals were sedated with Isoflurane and
then injected with Ketamine/xylazine mixture (80/12mg/ml at
8.1μl/g body weight = 0.6/0.097mg/g) to deeply anesthetize the
animal. The sufficiency of anesthesia was tested by checking paw
reflexes and pinching the tail. Surgical access to the heart was
implemented, and the animals were transcardially perfused with
oxygenated artificial cerebrospinal fluid containing (ACSF) com-
posed of (in mM): NaCl 124, KCl 5, NaH2PO4 3, MgSO4 2,
d-glucose 10, NaHCO3 26 and CaCl2 2 (290–300 mOsm, 7.3–
7.4 pH adjusted by 95% O2/5% CO2). Removal and extraction
of the brain/cerebellum was intentionally delayed (∼15min) to
match the timing in primates, and was performed in ice-cold,
O2 bubbled, low sodium/sucrose ACSF. In these animals, dose
response curves for EtOH were generated and compared to val-
ues obtained for NHP GCs and for the original group of SDRs.
Similar to the original group of SDRs, all SDR GCs responded
to all doses of EtOH tested (25, 52, 79, and 105mM), and the
magnitude of the response to each dose was significantly greater
(at least P < 0.05 for all doses tested) than the response in NHP
GCs, and not significantly different from the response in the orig-
inal group of SDRs. Accordingly, both sets of SDR values were
combined for final analysis/comparison to NHPs and for figure
presentation (Figure 3). For all preparations, parasagittal slices
(350μm) were made with a vibrating tissue slicer (Vibratome).
Slices were incubated in warmed (33 ± 1◦C), normal ACSF [in
mM: 124 NaCl, 26 NaHCO3, 1 NaH2PO4, 2.5 KCl, 2.5 CaCl2,
2 MgCl2, 10 D-glucose, and bubbled with 95%O2/5% CO2 (pH
7.4).] for 1 h after dissection, then maintained at room temper-
ature until used. Kynurenic acid (1mM) was included in the
holding solution (to block glutamate receptors to reduce poten-
tial excitotoxic damage) but was omitted from the experimental
solutions.
Electrophysiology
Recordings were made from 78 NHP and 71 SDR GCs from 25
and 27 animals, respectively. Slices were placed in a submersion
chamber on an upright microscope, and viewed with an Olympus
60× (0.9 numerical aperture) water immersion objective with
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differential interference contrast and infrared optics. Slices were
perfused with ACSF at a rate of ∼7ml/min at room tempera-
ture (22–24◦C). Drugs were dissolved in ACSF and applied by
bath perfusion. Visually identified GCs were voltage-clamped
(Vh = −60mV) with patch pipettes, constructed from thick-
walled borosilicate glass capillaries and filled with an internal
solution containing (in mM): CsCl 130, NaCl 4, CaCl2 0.5,
HEPES 10, EGTA 5, MgATP 4, Na2GTP 0.5, QX-314 5. Solutions
were pH adjusted to 7.2–7.3 with CsOH. Electrode resistance was
4–10 M. Cells were rejected if access resistance was greater than
15 M. This access resistance rejection threshold, combined with
GC input resistances of greater than 2G means that series resis-
tance errors were always less than 1%, and thus were not com-
pensated. Note, the intracellular [Cl−] sets ECl- to ∼0mV, which
for the holding potentials used in all experiments (−60mV),
results in GABAAR currents being inward (downward deflections
in displays of the holding current). Accordingly enhancement
and block/suppression of tonic GABAAR-mediated currents are
inward and outward, respectively. eIPSCs were elicited by plac-
ing a large patch-electrode (∼2 M), filled with ACSF into
the slice within a 500μm of the recorded cell, and increas-
ing the stimulus intensity (of 100μs duration) until a synap-
tic response was evoked. Complete blockade by the GABAAR
antagonist GABAzine (10μM) was used as confirmation that
the response was a GABAAR-mediated IPSC. Cells with residual
synaptic currents (presumably glutamatergic) we excluded from
analysis.
Immunocytochemistry
Slices were fixed in 4% paraformaldehyde in phosphate buffered
saline (PBS) for 17 h. Slices were then washed and incubated for
40min in blocking solution [PBS, 0.5% Triton X-100, and bovine
serum albumin (0.5mg/ml)]. Next, they were incubated for 1–2
days with primary antibody in PBS and Triton. Slices were washed
three times (10min each) in PBS, then incubated for 45min with
an Alexa-conjugated secondary antibody. Slices were mounted
in Citifluor and imaged with confocal microscopy. See reagents
below for source and dilution of antibodies used.
Confocal microscopy
Images were acquired with a Zeiss confocal LSM780 laser scan-
ning Microscope, using accompanying Zeiss software for acqui-
sition, processing and subsequent analysis. A laser line falling
within 20 nm of the peak absorbance was used for each of the
various fluorophores, with appropriate excitation, dichroic and
emission filters. Images were acquitted through a 40×, 1.4 N.A.
PlanApo oil-immersion objective. Pinhole diameter and slice step
thickness were optimized for the objective. For GABAAR subunit
distribution studies, stacks of image planes were acquired, and
then projected into a single stacked image (10μm thick). Images
in Figures 1D,E are representative of others obtained from three
separate animals, three slices from each animal, and five distinct
regions of each slice.
Analysis of GABAAR currents
Membrane currents were acquired at 20 kHz, filtered at 10 kHz,
and analyzed with pClamp (v.6.3) software (Axon Instruments,
Foster City, CA). For analysis and display of sIPSCs, data were
filtered at 2–5 kHz. When quantifying sIPSC occurrence, sIP-
SCs were defined as current deflections that have an amplitude
(measured from the mean current) greater than the peak-to-peak
amplitude of the current noise and with a decay time constant
at least 3-fold slower than the rise time. The tonic current was
assessed by fitting the Gaussian distribution of all data points not
skewed by synaptic events from a point 3 pA to the left of the peak
value to the rightmost (largest) value of the histogram distribu-
tion. Drug-induced changes in tonic GABAAR current magnitude
and sIPSC frequency were calculated by comparing the ampli-
tude/frequency in the drug vs. the mean amplitude/frequency of
the currents before and after drug application.
Statistics
All data are expressed as the mean ± the standard error of
the mean. For statistical comparisons between SDRs and NHPs,
unpaired Student’s t-tests were used, and paired Student’s t-tests
were used for within cell comparisons of effects of drugs on
synaptic responses. In all cases, we set the threshold for signifi-
cance at P < 0.05.
Reagents
All reagents were from Sigma Chemicals (St. Louis, MO)
except gabazine and kynurenic acid (all from Ascent scien-
tific, UK). Primary antibodies were (host/supplier/dilution): α6
subunit of GABAAR (rabbit/Millipore AB5610/1:200), δ sub-
unit of GABAAR (rabbit/Millipore AB9752/1:200), nNOS (rab-
bit/Cayman chemicals 160870/1:200), and Calbindin D-28K
(Rabbit/Chemicon/1:2000). Secondary antibodies were various
excitation maxima Alexafluors (Invitrogen) from appropriate
hosts diluted 1:500. For some antibodies (α6 and δ subunit of
GABAAR), specificity has been confirmed by lack of labeling in
relevant knockout mice, for others (Calbindin) specificity has
been confirmed by their labeling of a single band on western blots
(seemanufacturer website for details, and links therein). For those
antibodies where such confirmation of specificity was not already
available (nNOS), we confirmed specificity ourselves, by examin-
ing slices from nNOS knockout mice (Nos1tm1Plh homozygotes,
backcrossed to C57BL/6J mice for >10 generations, from Jackson
Laboratory), which did not display detectable nNOS staining
(Kaplan et al., 2013). Furthermore, for all of the antibodies we
used, the general qualitative expression pattern within the cere-
bellum is similar to what has been shown with other antibodies
in other reports and to our own studies with alternative anti-
bodies. Importantly, for all of the crucial immunohistochemical
studies (GABAAR subunits), we have conducted parallel elec-
trophysiological studies of the relevant proteins’ activity which
confirm our histochemical assessments (see electrophysiological




Monkey protocols were approved by the OregonNational Primate
Research Center Animal Care and Use Committee and were car-
ried out in Hillsboro, OR. Monkeys were sedated with ketamine
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(15mg/kg, i.m.) and hair was removed from the head, neck
and calves. A catheter was inserted into the saphenous vein
and secured to the skin with tape. After flushing with saline, a
surgical plane of anesthesia was established by slowly injecting
to effect 20–35mg/kg sodium pentobarbital through the intra-
venous catheter and flushing with an equal volume of saline. The
adequacy of surgical anesthesia was verified by the absence of the
corneal, palpebral, and hindlimbwithdrawal reflexes. Cardiac and
respiratory function and blood pressure were closely monitored
throughout the procedure by veterinarians. Incisions were made
in the scalp along the sagittal suture from bregma to the 3rd cer-
vical vertebra and perpendicularly along the coronal suture and
occipital ridge, after which the skull was exposed by reflecting the
temporal, frontal, and occipital muscles, by reflecting the muscles
along the sagittal suture and the occipital ridge. The craniotomy
was carried out using bone rongeurs after drilling a 1-cm diam-
eter hole in the right parietal bone. Once the bone was removed,
the calvaria was removed from the dura mater and the occipital
ridge was removed. The exposed brain was gently covered with
saline-soaked gauze. The animal was turned onto its back and
sequential incisions were made through the skin from the clav-
icle to the pelvis and then through the abdominal and pectoral
muscles and diaphragm. The ribcage was cut and the pericardium
was opened. The right atrium was cut to drop blood pressure
and a 16-gauge cannula was inserted into the ascending aorta
and clamped into place. The descending aorta was clamped in
the lower thorax. The animal was perfused with 1.5 L of oxy-
genated artificial cerebrospinal fluid containing (ACSF) in 2min
composed of (in mM): NaCl 124, KCl 5, NaH2PO4 3, MgSO4 2,
d-glucose 10, NaHCO3 26 and CaCl2 2 (290–300 mOsm, 7.3–
7.4 pH adjusted by 95% O2/5% CO2). Following perfusion, the
animal was immediately turned over and the dura mater was cut
at the posterior extent of the occipital lobes and along the mid-
sagittal line and reflected. The falx cerebri and tentorium cerebelli
were removed and the occipital lobes were elevated with a scalpel
handle. The cervical cord was cut at C3 using a scalpel and the
cranial nerves were bluntly dissected from the brain using the
scalpel’s handle. The brain was removed from the skull in a cau-
dal to rostral fashion. The brainstem was separated using a razor
blade by sectioning just rostral to the ponto-medullary junction
and by sectioning the cerebellar peduncles. The tissue block was
submerged in a small beaker of oxygenated, low-sodium, ice-cold
ACSF composed of sucrose 220, KCl 2, NaH2PO4 1.5, MgSO4 1.2,
d-glucose 10, NaHCO3 26, and CaCl2 0.2 and transported to the
electrophysiology laboratory. Once the cerebellum was isolated,
the remaining brain and tissues of the body were prepared for
additional studies by other investigators.
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